Anavex Life Sciences
AVXL
#7563
Rank
โ‚ฌ0.33 B
Marketcap
3,78ย โ‚ฌ
Share price
-1.12%
Change (1 day)
-47.36%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -โ‚ฌ47.22 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ44.28 Million a decrease over its 2023 earnings that were of -โ‚ฌ38.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ47.22 Million6.62%
2024 -โ‚ฌ44.28 Million14.77%
2023 -โ‚ฌ38.59 Million-17.49%
2022 -โ‚ฌ46.76 Million22.96%
2021 -โ‚ฌ38.03 Million35.36%
2020 -โ‚ฌ28.1 Million12.65%
2019 -โ‚ฌ24.94 Million29.09%
2018 -โ‚ฌ19.32 Million36.33%
2017 -โ‚ฌ14.18 Million17.11%
2016 -โ‚ฌ12.11 Million20.91%
2015 -โ‚ฌ10.01 Million-6.29%
2014 -โ‚ฌ10.68 Million337.28%
2013 -โ‚ฌ2.45 Million
2008 -โ‚ฌ4.52 Million106.01%
2007 -โ‚ฌ2.2 Million8848.98%
2006 -โ‚ฌ0.03 Million-79.99%
2005 -โ‚ฌ0.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚ฌ57.36 M-228.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ5.69 Million-87.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚ฌ56.31 M-225.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚ฌ14.86 Million-66.78%๐Ÿ‡บ๐Ÿ‡ธ USA